Stephane Bancel, CEO of Moderna Therapeutics, gives remarks during an announcement at the Moderna offices in Laval, Que., on Sept. 19, 2025. The Canadian Press/Christopher Katsarov
Moderna has produced the first Canadian-made doses of its mRNA vaccines in its new facility in Laval, Que., the company’s CEO says.
“We want to bring this mRNA technology to help as many people as we can,” Moderna CEO Stéphane Bancel said at a Sept. 19 press conference in Laval. “COVID is just the beginning. We have so many more exciting products coming in infectious disease, but also cancer, in rare genetic disease, and soon, I believe, in autoimmune disease.”
